At a private JP Morgan conference, Pharma investors were shown a chart projecting America's obesity rate going UP as…
Summary
A thread alleges that pharmaceutical companies and investors view GLP-1 drugs like Ozempic as lifetime medications since weight returns when people stop taking them, with evidence including a standing ovation at a JP Morgan conference when presented with data showing obesity rates rising alongside Ozempic prescriptions. The thread claims the industry has aggressively marketed these drugs to children, paid advocacy groups to promote them, and downplayed serious side effects including pancreatitis and eating disorders, while the actual obesity epidemic is driven by subsidized unhealthy foods.
Summarized by ThreadOut AI from the full thread. May miss nuance — read the thread below.
- #1
- #2
- #3
- #4
- #5
- #6
- #7
- #8